Livedoid vasculopathy: experience in using rituximab

Livedoid vasculopathy: experience in using rituximab

Saved in:

Bibliographic Details
Main Authors:	Tatyana Valentinovna Beketova, S K Solovyev, S G Radenska-Lopovok, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2011-08-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/350
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Livedoid vasculopathy: experience in using rituximab
by: Yuri Vladimirovich Muravyev, et al.
Published: (2011-08-01)

Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib
by: Parvin Mansouri, et al.
Published: (2025-06-01)

Livedoid Vasculopathy Successfully Treated With JAK Inhibitors
by: Antoine Delpuech, et al.
Published: (2025-06-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

A case report and literature review of livedoid vasculopathy in children
by: Jing Qu, et al.
Published: (2025-05-01)

Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy
by: John R. Edminister, et al.
Published: (2019-01-01)

Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review
by: Yu Liu, et al.
Published: (2025-12-01)

Successful healing of a chronic ulcer in livedoid vasculopathy using PuraPly: A case report
by: Sofia Angel, BS, et al.
Published: (2025-09-01)

[Translated article] Use of a Spinal Cord Stimulator to Treat Livedoid Vasculopathy: Effective Control of an Untreatable Disease
by: L. Revelles-Peñas, et al.
Published: (2024-11-01)

Baricitinib Successfully Treated a Teenager with Refractory Livedoid Vasculopathy: A Case Report and Literature Review
by: Liu C, et al.
Published: (2025-02-01)

Livedoid vasculopathy, calciphylaxis, and Martorell’s hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs
by: Priscila Neri Lacerda, et al.
Published: (2025-04-01)

Refractory reactivated VZV encephalitis with vasculopathy secondary to rituximab
by: Nisha A. George, et al.
Published: (2024-11-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

SUSAC'S SYNDROME (RETINOCOCHLEOCEREBRAL VASCULOPATHY)
by: T. V. Beketova, et al.
Published: (2018-05-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

EFFECT OF RITUXIMAB ON THE BLOOD CHOLESTEROL TRANSPORT SYSTEM IN PATIENTSWITH RHEUMATOID ARTHRITIS
by: Tatyana Valentinovna Popkova, et al.
Published: (2010-08-01)

Susac syndrome: The effectiveness of Rituximab monotherapy
by: T. V. Beketova
Published: (2023-06-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Diagnostic criteria for idiopathic inflammatory myopathies. Problems of their optimization
by: O. A. Antelava, et al.
Published: (2014-09-01)

Modem approach to classification criteria for idiopathic inflammatory myopathies
by: O A Antelava, et al.
Published: (2007-10-01)

Estimulador medular en la vasculopatía livedoide: control eficaz de una patología intratable
by: L. Revelles-Peñas, et al.
Published: (2024-11-01)

Morphological differential diagnosis of the main types of inflammatory myopathies
by: S. G. Radenska-Lopovok
Published: (2015-02-01)

Lupus nephritis: What new is in morphological diagnosis?
by: S G Radenska-Lopovok
Published: (2008-08-01)

Experience with Tixagevimab and Cilgavimab (Evusheld) in 86 rheumatic patients undergoing anti-B cell therapy with rituximab
by: T. V. Beketova, et al.
Published: (2023-04-01)

EXPERIENCE OF RITUXIMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alekseeva, et al.
Published: (2012-08-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Idiopathic polypoidal choroidal vasculopathy
by: Cekić Sonja, et al.
Published: (2012-01-01)

Cardiac allograft vasculopathy: current review
by: B. L. Mironkov, et al.
Published: (2024-07-01)

Polypoidal Choroidal Vasculopathy in Congolese Patients
by: Nelly N. Kabedi, et al.
Published: (2020-01-01)

Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2023-10-01)

Historical stages of the study of systemic necrotizing vasculitides
by: Tatiana Valentinovna Beketova
Published: (2012-06-01)

GRANULOMATOSIS WITH POLYANGIITIS, WHICH IS PATHOGENETICALLY ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES: CLINICAL FEATURES
by: Tatiana Valentinovna Beketova
Published: (2012-12-01)

Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)

Cutaneous Vasculopathy and Recalcitrant Lower-Extremity Ulcerations
by: Morgan E. Belina, et al.
Published: (2023-04-01)

Experience of Using Rituximab in a Girl with Severe Systemic Lupus Erythematosus
by: A. A. Lebedenko, et al.
Published: (2015-10-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

EXPERIENCE WITH EFFECTIVE COMBINED ANTI-B-CELL THERAPY WITH RITUXIMAB AND BELIMUMAB FOR REFRACTORY GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S) WITH SEVERE LUNG DAMAGE
by: T. V. Beketova, et al.
Published: (2017-03-01)

INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE
by: T. V. Beketova, et al.
Published: (2017-10-01)

The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2023-08-01)

Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01)